Today: 23 May 2026
RTX stock jumps after earnings beat, 2026 outlook; tariffs and defense orders in focus
28 January 2026
2 mins read

RTX stock jumps after earnings beat, 2026 outlook; tariffs and defense orders in focus

New York, January 27, 2026, 19:10 EST — After-hours

  • RTX shares climbed roughly 4% following fourth-quarter results and a 2026 outlook that exceeded some forecasts
  • Growth was fueled by jet-engine demand and commercial aircraft repairs, with defense spending holding steady
  • Investors are focused on tariffs, delivery-driven policy changes, and a fresh round of defense earnings this week

RTX shares climbed 3.7% to $201.28 in after-hours trading Tuesday. The aerospace and defense giant leaned on robust engine demand in its latest quarterly results and outlined targets for 2026.

This matters because RTX operates in two hot sectors: the jet-engine aftermarket, buoyed by airlines flying older planes longer, and defense programs still churning through a hefty backlog of orders.

This comes amid a stretch of defense-focused earnings. Traders are weighing if 2026 guidance represents a baseline or simply the growth plateau following a robust year.

RTX reported a 12% jump in fourth-quarter sales, reaching roughly $24.2 billion. Adjusted earnings came in at $1.55 per share. Looking ahead, the company projected adjusted sales between $92.0 billion and $93.0 billion for 2026, with adjusted earnings expected in the $6.60 to $6.80 per share range. Free cash flow, which is cash remaining after capital expenditures, is forecasted at $8.25 billion to $8.75 billion. The backlog sits at $268 billion. CEO Chris Calio noted the firm entered 2026 with “great momentum.” RTX

Pratt & Whitney, the company’s engine division, saw a boost from rising sales of the F135 engine that powers Lockheed Martin’s F-35, along with steady repair work on the older F100 engine, Reuters reported. CFO Neil Mitchill told Reuters that RTX expects around $600 million in tariff impacts in 2025. The company also highlighted new uncertainty following a Trump executive order linking buybacks, dividends, and executive pay to weapons delivery schedules. RTX paid $3.57 billion in dividends in 2025 and plans to increase investment in munitions facilities by $500 million in 2026, the report said.

“Adjusted” numbers exclude items the company claims aren’t part of its core run-rate. Investors track these for trends, but the real focus often moves to cash—how much flows in versus what’s tied up in inventory and programs.

Wall Street reacted fast. TD Cowen’s Gautam Khanna boosted his price target on RTX to $225. Not far behind, Vertical Research Partners’ Robert Stallard pushed his target even higher, to $227, reports StreetInsider.

Defense stocks stirred the pot Tuesday as Northrop Grumman released earnings, highlighting demand driven by geopolitical tensions. Still, its 2026 forecast fell short of some analyst expectations.

General Dynamics will hold its fourth-quarter earnings call on Wednesday, swiftly followed by Lockheed Martin’s session covering both fourth-quarter and full-year results on Thursday morning.

Investors remain on edge despite a smooth quarter. Pratt & Whitney is under the microscope for engine availability issues, while Airbus has flagged that it hasn’t yet struck a deal with the engine maker on supply volumes “for the foreseeable future.” Reuters

Traders will be eyeing whether RTX can sustain its post-earnings move during Wednesday’s session. They’ll also be tracking any shifts in tone on 2026 budgets, delivery timelines, and pricing power from other defense primes’ commentary.

Stock Market Today

  • Morinaga Milk Industry Valuation Post Stock Split Highlights Potential Undervaluation
    May 23, 2026, 12:51 AM EDT. Morinaga Milk Industry (TSE:2264) approved a stock split effective July 1, 2026, boosting investor interest. The stock price gained 4.64% last week and 25.92% year-to-date, with a 1-year total shareholder return of 49.37%. Trading at a price-to-earnings (P/E) ratio of 17x, below the peer average of 33.6x but above the Japanese food industry average of 15.3x, the valuation reflects mixed signals. While the P/E suggests fair value relative to earnings, discounted cash flow (DCF) analysis estimates intrinsic value nearly double the current price, indicating potential undervaluation. Investors face a choice between P/E-based market pricing and deeper value suggested by future cash flow. The developments warrant close monitoring of growth prospects and governance changes at Morinaga Milk Industry.

Latest articles

Dow Hits Record Close; All Eyes Turn to Holiday-Week Trading

Dow Hits Record Close; All Eyes Turn to Holiday-Week Trading

23 May 2026
The Dow closed at a record 50,579.70 on Friday, while the S&P 500 notched its eighth straight weekly gain. After-hours trading saw SPY, QQQ, DIA, and IWM all move lower. U.S. markets will be closed Monday for Memorial Day. Investors await Thursday’s inflation data.
IREN Stock Pauses as Nvidia Rally Cools Before Holiday

IREN Stock Pauses as Nvidia Rally Cools Before Holiday

23 May 2026
IREN shares fell 2.1% to $56.83 Friday, ending a two-day rally but closing the week up 7.4%. The stock’s moves follow a $3.4 billion AI cloud deal with Nvidia and a $3 billion convertible note offering. March-quarter revenue dropped to $144.8 million, with a net loss of $247.8 million. U.S. markets close Monday for Memorial Day; trading resumes Tuesday.
AXT stock reaches record; investors weigh risk to rally

AXT stock reaches record; investors weigh risk to rally

23 May 2026
AXT shares jumped 16.37% to $140.83 on Friday, hitting a 52-week high and trading above all recent analyst targets. The surge followed strong demand for AI-linked optical networking hardware and a sharp rise in indium phosphide orders. First-quarter revenue climbed to $26.9 million, with gross margin turning positive. Management forecast Q2 profitability and a backlog over $100 million.
Texas Instruments stock jumps after upbeat forecast, new data-center disclosure grabs focus
Previous Story

Texas Instruments stock jumps after upbeat forecast, new data-center disclosure grabs focus

Johnson & Johnson stock climbs after fresh FDA Darzalex Faspro nod — what investors watch next
Next Story

Johnson & Johnson stock climbs after fresh FDA Darzalex Faspro nod — what investors watch next

Go toTop